Journals / Çukurova Üniversitesi Tıp Fakültesi Dergisi / 1998 / Cilt: 23 - Sayı: 1

Retinopathy of prematurity and risk factors

Prematüre retinopatisi ve risk faktörleri

Pages
29–34
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings show the importance of ROP screening program in preterm infants.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Retinopathy of prematurity and risk factors.
📊
Key Findings & Data:In this study 105 premature infants with gestational ages less than 37 weeks evaluated for frequency of retinopathy of prematurity (ROP), risk factors and results of treatment in the Neonatology Unit of the Çukurova University Faculty of Medicine between January 1995 and January 1997.
💡
Conclusion & Impact:These findings show the importance of ROP screening program in preterm infants.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Retinopathy of prematurity and risk factors. In this study 105 premature infants with gestational ages less than 37 weeks evaluated for frequency of retinopathy of prematurity (ROP), risk factors and results of treatment in the Neonatology Unit of the Çukurova University Faculty of Medicine between January 1995 and January 1997. ROP was diagnosed 14 premature infants (14.4 %) and 20 eyes (10.4 %). Seven of these cases were stage I, six of them stage II, and seven of them stage III. Cryotherapy was performed on stage III eyes. There was a significant association between birth weight, acidosis, sepsis, apnea, duration of oxygen therapy, Apgar score, blood transfusion, total parenteral nutrition and development of ROP. These findings show the importance of ROP screening program in preterm infants.

Özet

Yenidoğan Yoğun Bakım Unitesi'nde Ocak 1995-Ocak 1997 tarihleri arasında izlenen 37 haftanın altında gestasyon yaşı olan ve 4 haftadan uzun süre izlenen 105 olgu prematürite retinopatisi (ROP) gelişimi, risk faktörleri ve tedavi sonuçları yönünden değerlendirildi. Takibi yapılan 97 bebeğin (194 göz), 14'ünün (%14.4) 20 gözünde (%10.4) retinopati saptandı. ROP (+) bebeklerin 13'ü (%92.8) 32 hafta ve altında gestasyon yasına, bir olgu ise (%7.2) 35 haftalık gestasyon yaşına sahipti. 7 gözde Evre l, 6 gözde Evre II, 7 gözde Evre III ROP geliştiği saptandı. Evre III gelişen olgulara kriyoterapi uygulandı. Doğum ağırlığı düşük olan, asidoz, sepsis ve apne gelişen, uzun süre oksijen tedavisi alan, 5. dakika APGAR skoru 7'nin altında olan, kan transfüzyonu uygulanan ve total parenteral beslenen bebeklerde ROP gelişme riskinin daha fazla olduğu belirlendi. ROP tanısının erken konulması ve müdahelenin yapılması ile ciddi göz komplikasyonlarının önlenmesi açısından ROP taramasının önemi vurgulandı.

🔖

Cite This Article

SATAR, M., NARLI, N., ÖZCAN, A., SOYLU, M. (2022). Retinopathy of prematurity and risk factors. Çukurova Üniversitesi Tıp Fakültesi Dergisi, Cilt: 23 - Sayı: 1, 29–34. https://ajindex.com/articles/486260

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Arsan S, Gültan E, Koç E ve ark: Prematüre Retinopatisi: Ýlk Tarama Sonuçlarýmýz. MN Pediatride Yöneliþler 1994; 1/3-4, 134-140
  2. Clark C, Gibbs JAH, Maniello R et al: Blood transfusion: A possible risk factor in retrolental fibroplasia. Acta Pediatr Scand 1981; 70: 535-539
  3. Cryotherapy of Prematurity Cooparative Group: Multicenter trial of cryotherapy for retinopathy of prematurity: Preliminary results. Arch Ophthalmol 1988; 106: 471-479
  4. Fauchere JC, Meier-Gibbons FE, Koerner F et al: ROP and bilirubin- no clinical evidence for a benefical role of bilirubin as a physiological anti-oxidant. Eur J Pediatr 1994; 153: 358-362
  5. Fielder AR, Levene MI: Screening for retinopathy of prematurity. Arch Dis Child 1992; 67: 860-867
  6. Flynn JT, Bancalari E, Synder ES et al: A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Eng J Med 1992; 326: 1050-1054
  7. Gibson DL, Sheps SB, Uh SH et al: Retinopathy of Prematurity-Induced Blindness: Birth Weight-Specific Survival and the New Epidemic. Pediatrics 1990; 86:3, 405-412
  8. Gunn TR, Easdown J, Outerbridge EW et al: Risk factors in retrolental fibroplasia. Pediatrics 1980; 65: 1096-1100
  9. Hegyi T, Goldie E, Hiatt M: The protective role of bilirubin in oxygen-radical diseases of the preterm infant. J Perinatal 1994; 14: 296-300
  10. Holmström G, El Azazi M, Jacobson I, Lennerutrand G: A population based, prospective study of the development of ROP in prematurely born children in the Stockholm area of Sweden. British J Opthalmol 1993; 77: 417-423
  11. Hunter DG, Shizuo M: Retinopathy of prematurity: pathogenesis, diagnosis, and treatment. Int Ophthalmol Clin 1992; 32: 163- 183
  12. Karadeniz Þ, Can G, Çoban A ve ark. Prematüre retinopatisi ve kendi olgularýmýz. III. Çapa Neonatoloji Günleri Kongre Kitabý. 4-6 Ekim 1995, s 200
  13. Lucey JF, Dangman B: A Reexamination of the Role of Oxygen in Retrolental Fibroplasia. Pediatrics 1984; 73:1, 82-96
  14. Phelps DL: Retinopathy of prematurity: An estimate of vision loss in the United States-1979. Pediatrics 1981; 67: 924-925
  15. Purohit DM, Ellison CR, Zierler S et al. Risk factors for retrolental fibroplasia: Experience with 3,025 premature infants. Pediatrics 1985; 76:3, 339-344
  16. Rankin SJA, Tubman TRJ, Halliday HL, Jonston SS: Surfactant and ROP incidence (letter). Ophthalmolohy 1991; 98: 1148-1149
  17. Repka MX, Hudak ML, Parsa CF et al: Calf lung surfactant extract prophylaxis and retinopat